Your session is about to expire
← Back to Search
Intrauterine Device
Mirena Intrauterine System for Birth Control
Phase < 1
Waitlist Available
Research Sponsored by University of Oklahoma
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
18 years or older
desire an intrauterine device as postpartum contraception
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights
Study Summary
This trial will compare the expulsion and discontinuation rates of postpartum intrauterine devices (IUDs) placed immediately after delivery versus IUDs placed during a follow-up visit.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, an average of 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Expulsion of intrauterine contraception
Secondary outcome measures
Discontinuation of intrauterine contraception
Trial Design
2Treatment groups
Experimental Treatment
Group I: Contraceptive MirenaExperimental Treatment1 Intervention
Determination of expulsion and discontinuation rates in participants randomly allocated to receive levonorgestrel intrauterine systems Mirena Intrauterine System
Group II: Contraceptive KyleenaExperimental Treatment1 Intervention
Determination of expulsion and discontinuation rates in participants randomly allocated to receive levonorgestrel intrauterine systems Kyleena Intrauterine System
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Levonorgestrel
FDA approved
Levonorgestrel
FDA approved
Find a Location
Who is running the clinical trial?
University of OklahomaLead Sponsor
455 Previous Clinical Trials
98,273 Total Patients Enrolled
Valorie Owens, MSWStudy DirectorUniversity of Oklahoma
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger